Global Artificial Organ & Bionics 麻豆原创 Insights, Forecast to 2029

Publication ID:

PB503230633

Publication Date:

March 29, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The Artificial Organs are made by a human and are implemented in human bodies with living tissue, it can able to perform the original function of human body parts. Bionics refers to replacement or improvement of body parts by mechanical kinds.
麻豆原创 Analysis and Insights: Global Artificial Organ & Bionics 麻豆原创
The global Artificial Organ & Bionics market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Artificial Organ & Bionics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Artificial Organ & Bionics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Artificial Organ & Bionics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Artificial Organ & Bionics include Abiomed, Asahi Kasei Kuraray Medical, Thoratec, WorldHeart, Gambro AB, Guanhao Biotech, Venus Medtech, Weigao Medical Polymer and Zhenghai Bio-Tech, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Artificial Organ & Bionics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Artificial Organ & Bionics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Organ & Bionics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Artificial Organ & Bionics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Artificial Organ & Bionics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Artificial Organ & Bionics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abiomed, Asahi Kasei Kuraray Medical, Thoratec, WorldHeart, Gambro AB, Guanhao Biotech, Venus Medtech, Weigao Medical Polymer and Zhenghai Bio-Tech, etc.
By Company
Abiomed
Asahi Kasei Kuraray Medical
Thoratec
WorldHeart
Gambro AB
Guanhao Biotech
Venus Medtech
Weigao Medical Polymer
Zhenghai Bio-Tech
Segment by Type
Mechanical Bionics
Electronic Bionics
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Artificial Organ & Bionics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Organ & Bionics companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Organ & Bionics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Artificial Organ & Bionics 麻豆原创 Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Mechanical Bionics
1.2.3 Electronic Bionics
1.3 麻豆原创 by Application
1.3.1 Global Artificial Organ & Bionics 麻豆原创 Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Organ & Bionics 麻豆原创 Perspective (2018-2029)
2.2 Global Artificial Organ & Bionics Growth Trends by Region
2.2.1 Artificial Organ & Bionics 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Organ & Bionics Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Artificial Organ & Bionics Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Artificial Organ & Bionics 麻豆原创 Dynamics
2.3.1 Artificial Organ & Bionics Industry Trends
2.3.2 Artificial Organ & Bionics 麻豆原创 Drivers
2.3.3 Artificial Organ & Bionics 麻豆原创 Challenges
2.3.4 Artificial Organ & Bionics 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Artificial Organ & Bionics by Players
3.1.1 Global Artificial Organ & Bionics Revenue by Players (2018-2023)
3.1.2 Global Artificial Organ & Bionics Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Artificial Organ & Bionics 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Artificial Organ & Bionics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Artificial Organ & Bionics 麻豆原创 Concentration Ratio
3.4.1 Global Artificial Organ & Bionics 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Organ & Bionics Revenue in 2022
3.5 Global Key Players of Artificial Organ & Bionics Head office and Area Served
3.6 Global Key Players of Artificial Organ & Bionics, Product and Application
3.7 Global Key Players of Artificial Organ & Bionics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Organ & Bionics Breakdown Data by Type
4.1 Global Artificial Organ & Bionics Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Artificial Organ & Bionics Forecasted 麻豆原创 Size by Type (2024-2029)
5 Artificial Organ & Bionics Breakdown Data by Application
5.1 Global Artificial Organ & Bionics Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Artificial Organ & Bionics Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Artificial Organ & Bionics 麻豆原创 Size (2018-2029)
6.2 North America Artificial Organ & Bionics 麻豆原创 Size by Type
6.2.1 North America Artificial Organ & Bionics 麻豆原创 Size by Type (2018-2023)
6.2.2 North America Artificial Organ & Bionics 麻豆原创 Size by Type (2024-2029)
6.2.3 North America Artificial Organ & Bionics 麻豆原创 Share by Type (2018-2029)
6.3 North America Artificial Organ & Bionics 麻豆原创 Size by Application
6.3.1 North America Artificial Organ & Bionics 麻豆原创 Size by Application (2018-2023)
6.3.2 North America Artificial Organ & Bionics 麻豆原创 Size by Application (2024-2029)
6.3.3 North America Artificial Organ & Bionics 麻豆原创 Share by Application (2018-2029)
6.4 North America Artificial Organ & Bionics 麻豆原创 Size by Country
6.4.1 North America Artificial Organ & Bionics 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Artificial Organ & Bionics 麻豆原创 Size by Country (2018-2023)
6.4.3 North America Artificial Organ & Bionics 麻豆原创 Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Artificial Organ & Bionics 麻豆原创 Size (2018-2029)
7.2 Europe Artificial Organ & Bionics 麻豆原创 Size by Type
7.2.1 Europe Artificial Organ & Bionics 麻豆原创 Size by Type (2018-2023)
7.2.2 Europe Artificial Organ & Bionics 麻豆原创 Size by Type (2024-2029)
7.2.3 Europe Artificial Organ & Bionics 麻豆原创 Share by Type (2018-2029)
7.3 Europe Artificial Organ & Bionics 麻豆原创 Size by Application
7.3.1 Europe Artificial Organ & Bionics 麻豆原创 Size by Application (2018-2023)
7.3.2 Europe Artificial Organ & Bionics 麻豆原创 Size by Application (2024-2029)
7.3.3 Europe Artificial Organ & Bionics 麻豆原创 Share by Application (2018-2029)
7.4 Europe Artificial Organ & Bionics 麻豆原创 Size by Country
7.4.1 Europe Artificial Organ & Bionics 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Artificial Organ & Bionics 麻豆原创 Size by Country (2018-2023)
7.4.3 Europe Artificial Organ & Bionics 麻豆原创 Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Artificial Organ & Bionics 麻豆原创 Size (2018-2029)
8.2 China Artificial Organ & Bionics 麻豆原创 Size by Type
8.2.1 China Artificial Organ & Bionics 麻豆原创 Size by Type (2018-2023)
8.2.2 China Artificial Organ & Bionics 麻豆原创 Size by Type (2024-2029)
8.2.3 China Artificial Organ & Bionics 麻豆原创 Share by Type (2018-2029)
8.3 China Artificial Organ & Bionics 麻豆原创 Size by Application
8.3.1 China Artificial Organ & Bionics 麻豆原创 Size by Application (2018-2023)
8.3.2 China Artificial Organ & Bionics 麻豆原创 Size by Application (2024-2029)
8.3.3 China Artificial Organ & Bionics 麻豆原创 Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Artificial Organ & Bionics 麻豆原创 Size (2018-2029)
9.2 Asia Artificial Organ & Bionics 麻豆原创 Size by Type
9.2.1 Asia Artificial Organ & Bionics 麻豆原创 Size by Type (2018-2023)
9.2.2 Asia Artificial Organ & Bionics 麻豆原创 Size by Type (2024-2029)
9.2.3 Asia Artificial Organ & Bionics 麻豆原创 Share by Type (2018-2029)
9.3 Asia Artificial Organ & Bionics 麻豆原创 Size by Application
9.3.1 Asia Artificial Organ & Bionics 麻豆原创 Size by Application (2018-2023)
9.3.2 Asia Artificial Organ & Bionics 麻豆原创 Size by Application (2024-2029)
9.3.3 Asia Artificial Organ & Bionics 麻豆原创 Share by Application (2018-2029)
9.4 Asia Artificial Organ & Bionics 麻豆原创 Size by Region
9.4.1 Asia Artificial Organ & Bionics 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Artificial Organ & Bionics 麻豆原创 Size by Region (2018-2023)
9.4.3 Asia Artificial Organ & Bionics 麻豆原创 Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size (2018-2029)
10.2 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size by Type
10.2.1 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size by Application
10.3.1 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size by Country
10.4.1 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Artificial Organ & Bionics 麻豆原创 Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abiomed
11.1.1 Abiomed Company Details
11.1.2 Abiomed Business Overview
11.1.3 Abiomed Artificial Organ & Bionics Introduction
11.1.4 Abiomed Revenue in Artificial Organ & Bionics Business (2018-2023)
11.1.5 Abiomed Recent Developments
11.2 Asahi Kasei Kuraray Medical
11.2.1 Asahi Kasei Kuraray Medical Company Details
11.2.2 Asahi Kasei Kuraray Medical Business Overview
11.2.3 Asahi Kasei Kuraray Medical Artificial Organ & Bionics Introduction
11.2.4 Asahi Kasei Kuraray Medical Revenue in Artificial Organ & Bionics Business (2018-2023)
11.2.5 Asahi Kasei Kuraray Medical Recent Developments
11.3 Thoratec
11.3.1 Thoratec Company Details
11.3.2 Thoratec Business Overview
11.3.3 Thoratec Artificial Organ & Bionics Introduction
11.3.4 Thoratec Revenue in Artificial Organ & Bionics Business (2018-2023)
11.3.5 Thoratec Recent Developments
11.4 WorldHeart
11.4.1 WorldHeart Company Details
11.4.2 WorldHeart Business Overview
11.4.3 WorldHeart Artificial Organ & Bionics Introduction
11.4.4 WorldHeart Revenue in Artificial Organ & Bionics Business (2018-2023)
11.4.5 WorldHeart Recent Developments
11.5 Gambro AB
11.5.1 Gambro AB Company Details
11.5.2 Gambro AB Business Overview
11.5.3 Gambro AB Artificial Organ & Bionics Introduction
11.5.4 Gambro AB Revenue in Artificial Organ & Bionics Business (2018-2023)
11.5.5 Gambro AB Recent Developments
11.6 Guanhao Biotech
11.6.1 Guanhao Biotech Company Details
11.6.2 Guanhao Biotech Business Overview
11.6.3 Guanhao Biotech Artificial Organ & Bionics Introduction
11.6.4 Guanhao Biotech Revenue in Artificial Organ & Bionics Business (2018-2023)
11.6.5 Guanhao Biotech Recent Developments
11.7 Venus Medtech
11.7.1 Venus Medtech Company Details
11.7.2 Venus Medtech Business Overview
11.7.3 Venus Medtech Artificial Organ & Bionics Introduction
11.7.4 Venus Medtech Revenue in Artificial Organ & Bionics Business (2018-2023)
11.7.5 Venus Medtech Recent Developments
11.8 Weigao Medical Polymer
11.8.1 Weigao Medical Polymer Company Details
11.8.2 Weigao Medical Polymer Business Overview
11.8.3 Weigao Medical Polymer Artificial Organ & Bionics Introduction
11.8.4 Weigao Medical Polymer Revenue in Artificial Organ & Bionics Business (2018-2023)
11.8.5 Weigao Medical Polymer Recent Developments
11.9 Zhenghai Bio-Tech
11.9.1 Zhenghai Bio-Tech Company Details
11.9.2 Zhenghai Bio-Tech Business Overview
11.9.3 Zhenghai Bio-Tech Artificial Organ & Bionics Introduction
11.9.4 Zhenghai Bio-Tech Revenue in Artificial Organ & Bionics Business (2018-2023)
11.9.5 Zhenghai Bio-Tech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abiomed
Asahi Kasei Kuraray Medical
Thoratec
WorldHeart
Gambro AB
Guanhao Biotech
Venus Medtech
Weigao Medical Polymer
Zhenghai Bio-Tech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.